Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)-Reference-Cited by-同舟云学术

Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)

Published:2014-04 Issue:2 Volume:56 Page:135-158
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatr Int

Author:

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ped.12317/fullpdf

Reference120 articles.

1. Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey;Nakamura;J. Epidemiol.,2012

2. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition);Ayusawa;Pediatr. Int.,2005

3. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides;Jennette;Arthritis Rheum.,2013

4. Kawasaki disease. With particular emphasis on arterial lesions;Naoe;Acta Pathol. Jpn,1991

5. Diagnosis and prognosis of coronary artery lesions in Kawasaki disease. Coronary angiography and the conditions for its application (a score chart);Asai;Nihon Rinsho.,1983

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary artery complications in patients with Kawasaki disease who successfully responded to the standard initial IVIG treatment;Archives of Disease in Childhood;2024-09-03

2. The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease;Pediatrics & Neonatology;2024-09

3. Decreased Serum Apolipoprotein CIII in the Acute Phase of Kawasaki Disease;Pediatric Cardiology;2024-07-02

4. Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial;American Heart Journal;2024-07

5. Jaundice-predominant manifestation of Kawasaki disease in children;Frontiers in Pediatrics;2024-01-09